Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 5144-89-8 Chemical Structure| 5144-89-8

Structure of o-Phenanthroline monohydrate
CAS No.: 5144-89-8

Chemical Structure| 5144-89-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

1, 10-Phenanthroline Monohydrate an inhibitor of metallopeptidases.

Synonyms: 1,10-Phenanthroline monohydrate; 1,10-Phenanthroline (hydrate); o-Phenanthroline

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of o-Phenanthroline monohydrate

CAS No. :5144-89-8
Formula : C12H10N2O
M.W : 198.22
SMILES Code : [H]O[H].C12=NC=CC=C1C=CC3=CC=CN=C23
Synonyms :
1,10-Phenanthroline monohydrate; 1,10-Phenanthroline (hydrate); o-Phenanthroline
MDL No. :MFCD00149973
InChI Key :PPQJCISYYXZCAE-UHFFFAOYSA-N
Pubchem ID :21226

Safety of o-Phenanthroline monohydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H410
Precautionary Statements:P264-P270-P273-P301+P310+P330-P391-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF7 cells 100 μM 2 min Inhibition of platelet aggregation induced by avb3/MT1-MMP cells Br J Pharmacol. 2004 Jan;141(2):241-52.
MM.1S cells 10 µM 24 h Analyzed DNA content, results showed OPA treatment led to increased S phase and G2/M phase growth arrest Oncogene. 2017 Oct 5;36(40):5631-5638.
HT1080 fibrosarcoma cells 500 μM 3 min Inhibited tumour cell-induced platelet aggregation, significantly reduced TCIPA Br J Pharmacol. 2011 Apr;162(7):1577-89.
59M adenocarcinoma cells 500 μM 3 min Inhibited tumour cell-induced platelet aggregation, significantly reduced TCIPA Br J Pharmacol. 2011 Apr;162(7):1577-89.
Corynebacterium Ax20 cell extract 0.5 mM 2 h o-Phenanthroline blocked the release from the Cys-Gly-( S) conjugate but did not affect cleavage of the Cys-( S) conjugate, indicating that in a first step, a metal-dependent dipeptidase hydrolyzes the Cys-Gly bond. J Biol Chem. 2008 Jul 25;283(30):20645-52.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MM.1S tumor model Intraperitoneal injection 20 mg/kg 3 times per week for 18 days Evaluated the effect of OPA on tumor growth, results showed OPA reduced tumor progression and extended survival time in mice Oncogene. 2017 Oct 5;36(40):5631-5638.
BALB/c nude mice Ovarian cancer xenograft model Intraperitoneal injection 25 mg/kg Every 3 days for 15 days OPA inhibited the growth of ovarian cancer xenografts. Mol Oncol. 2021 Dec;15(12):3639-3658

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.04mL

1.01mL

0.50mL

25.22mL

5.04mL

2.52mL

50.45mL

10.09mL

5.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories